A new clinical age of aging research

Z Zhang, R Yang, Z Zi, B Liu - Trends in Endocrinology & Metabolism, 2024 - cell.com
Aging is a major risk factor for a variety of diseases, thus, translation of aging research into
practical applications is driven by the unmet need for existing clinical therapeutic options …

The critical role of biomarkers for drug development targeting the biology of aging

M Owen, N Bose, L Nisenbaum, KA Partrick… - The Journal of …, 2023 - Springer
Alzheimer's disease is a devastating neurodegenerative disorder that poses a significant
societal burden. Approval of anti-amyloid antibody therapies is a significant milestone for …

Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives

A Biţă, IR Scorei, MV Ciocîlteu, OE Nicolaescu… - Molecules, 2023 - mdpi.com
Many studies have suggested that the oxidized form of nicotinamide adenine dinucleotide
(NAD+) is involved in an extensive spectrum of human pathologies, including …

[HTML][HTML] Advances in the synthesis and physiological metabolic regulation of nicotinamide mononucleotide

C Zheng, Y Li, X Wu, L Gao, X Chen - Nutrients, 2024 - mdpi.com
Nicotinamide mononucleotide (NMN), the direct precursor of nicotinamide adenine
dinucleotide (NAD+), is involved in the regulation of many physiological and metabolic …

The emerging importance of NAD+ metabolome for nutrition and food sciences: A bibliometric analysis

GFS Alegre, GM Pastore - Food Bioscience, 2023 - Elsevier
NAD+ is crucial for cellular balance in all organisms. Recent interest has focused on its
metabolism. Deficiency-related issues can be countered using NMN and NR, potential …

NAD+-boosting compounds enhance nitric oxide production and prevent oxidative stress in endothelial cells exposed to plasma from patients with COVID-19

KA Freeberg, KR Ludwig, M Chonchol, DR Seals… - Nitric Oxide, 2023 - Elsevier
Abstract SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), induces
vascular endothelial dysfunction, but the mechanisms are unknown. We tested the …

Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial

MM McDermott, CR Martens, KJ Domanchuk… - Nature …, 2024 - nature.com
People with lower extremity peripheral artery disease (PAD) have increased oxidative
stress, impaired mitochondrial activity, and poor walking performance. NAD+ reduces …

Is there a role for novel supplements in the management of fatigue in rheumatic diseases?

T Khoo, M Jani, H Chinoy - RMD open, 2024 - rmdopen.bmj.com
Fatigue is a common symptom of rheumatic diseases and frequently persists even when
patients are in a near-remission state. In seeking options to manage troublesome symptoms …

Acute nicotinamide riboside supplementation increases human cerebral NAD+ levels in vivo

RPR Nanga, CE Wiers, MA Elliott… - Magnetic resonance …, 2024 - Wiley Online Library
Purpose The purpose of this study was to determine the effect of acute nicotinamide riboside
(NR) supplementation on cerebral nicotinamide adenine dinucleotide (NAD+) levels in the …

NAD+ enhancers as therapeutic agents in the cardiorenal axis

M Marín-Blázquez, J Rovira, MJ Ramírez-Bajo… - Cell Communication and …, 2024 - Springer
Cardiorenal diseases represent a complex interplay between heart failure and renal
dysfunction, being clinically classified as cardiorenal syndromes (CRS). Recently, the …